SaarLB Taps Regis-TR and Banksysteme Aktiengesellschaft for Derivatives Transactions Reporting

deutsche-borse-headquarters-eschborn

European trade repository Regis-TR, formed by Bolsas y Mercados Españoles (BME) and Deutsche Börse Group, and German financial services software provider Banksysteme Aktiengesellschaft (BS), announced it will facilitate a joint solution for Franco-German regional bank Landesbank Saar’s (SaarLB’s) over-the-counter (OTC) derivatives transactions reporting.

SaarLB follows other private German banking institutions in choosing the solution, which will be implemented in the first half of this year.

European Securities and Markets Authority (ESMA) regulations will require daily reporting of derivatives trading to a centralized transaction register, one of is which Luxembourg-based Regis-TR. BS, meanwhile, has developed a standard interface and messaging service for institutions to connect with.

"With the signing of this agreement, SaarLB will be able to implement the reporting requirements in a timely manner. The bank will also perform automated reporting of financial statements for its clients. Thus, SaarLB can assist small and medium-sized enterprises (SMEs) in implementing the statutory requirements as well,” says Werner Severin, vice chairman of SaarLB.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Nasdaq reshuffles tech divisions post-Adenza

Adenza is now fully integrated into the exchange operator’s ecosystem, bringing opportunities for new business and a fresh perspective on how fintech fits into its strategy.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here